Ā
š Key Points
To legally prescribe or furnish controlled substances (Schedules IIāV) under a supervising physician in California, a Nurse Practitioner must possess and maintain these four active credentials:
-
Active RN & NP Licensure: Must hold valid, active California licenses for both Registered Nursing and Nurse Practitioner status.
Ā -
NP Furnishing Number: Issued by the California Board of Registered Nursing (BRN), granting the foundational authority to order and furnish medications.
Ā -
Individual DEA Registration: An independent DEA number tied to the NP's California furnishing license (covering Schedules IIāV). NPs cannot prescribe controlled substances under a supervising physician's DEA number.
Ā - CURES (PDMP) Account: Active registration with Californiaās Prescription Drug Monitoring Program.
ā ļø Mandate: The NP must query CURES prior to prescribing a Schedule IIāIV controlled substance at every single visits
1ļøā£ Steps RequiredĀ Ā Ā
To maintain clinical alignment and support oversight protocols for controlled substances (CS), BESA Health requires the following collaborative communication workflow:
-
Mandatory Notification for CS Prescribing: For every patient encounter where a Controlled Substance (CS) medication is newly prescribed, adjusted, or refilled, the prescribing Advanced Practice Provider (APP) must route a note comment or task notification directly to the Supervising Physician within the Electronic Health Record (EHR) on the same day as the encounter.
Ā -
What to Include: The notification should briefly state the patientās clinical status, confirmation of a completed Prescription Drug Monitoring Program (PDMP) query, and the rationale for the CS prescription.
Ā - Oversight Compliance: This collaborative documentation ensures seamless clinical transparency, supports the Supervising Physician's oversight requirements, and maintains our commitment to patient safety and quality care.
Ā
Ā
If you have any questions or would like more information, please reach out to the Delegating Physician.Ā

Comments (0)